Marshall Wace’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
100,778
+85,867
| +576% | +$947K | ﹤0.01% | 1680 |
|
|
2025
Q1 | $133K | Sell |
14,911
-51,156
| -77% | -$457K | ﹤0.01% | 2333 |
|
|
2024
Q4 | $622K | Sell |
66,067
-83,993
| -56% | -$790K | ﹤0.01% | 1821 |
|
|
2024
Q3 | $1.21M | Sell |
150,060
-147,439
| -50% | -$1.19M | ﹤0.01% | 1450 |
|
|
2024
Q2 | $2.52M | Buy |
297,499
+135,426
| +84% | +$1.15M | ﹤0.01% | 1151 |
|
|
2024
Q1 | $1.45M | Buy |
+162,073
| New | +$1.45M | ﹤0.01% | 1307 |
|
|
2023
Q4 | – | Sell |
-20,400
| Closed | -$176K | – | 2279 |
|
|
2023
Q3 | $176K | Sell |
20,400
-39,412
| -66% | -$340K | ﹤0.01% | 1686 |
|
|
2023
Q2 | $619K | Buy |
+59,812
| New | +$619K | ﹤0.01% | 1520 |
|
|
2020
Q3 | – | Sell |
-14,990
| Closed | -$315K | – | 1879 |
|
|
2020
Q2 | $315K | Buy |
+14,990
| New | +$315K | ﹤0.01% | 1284 |
|
|
2019
Q2 | – | Sell |
-4,080
| Closed | -$92K | – | 1789 |
|
|
2019
Q1 | $92K | Hold |
4,080
| – | – | ﹤0.01% | 1436 |
|
|
2018
Q4 | $104K | Buy |
+4,080
| New | +$104K | ﹤0.01% | 1356 |
|
|
2017
Q1 | – | Sell |
-408,880
| Closed | -$13M | – | 716 |
|
|
2016
Q4 | $13M | Buy |
408,880
+329,812
| +417% | +$10.5M | 0.09% | 267 |
|
|
2016
Q3 | $2.87M | Buy |
79,068
+55,362
| +234% | +$2.01M | 0.02% | 516 |
|
|
2016
Q2 | $538K | Buy |
+23,706
| New | +$538K | ﹤0.01% | 802 |
|